(1) Any facility with both a closed-door pharmacy license and a license for medical cannabis processing shall ensure the physical separation of medical cannabis, which includes:
- (a) separating medical cannabis intended for home delivery from medical cannabis in the processing facility;
- (b) prohibiting the processing of medical cannabis materials in rooms designated as closed-door pharmacy areas;
- (c) clearly labeling medical cannabis intended for home delivery in the closed-door pharmacy;
(d) storing closed-door pharmacy products and medical cannabis processor cannabis in separate secure rooms that are not accessible from the other licensed facility.
- (i) Final product, raw material, or processed material in inventory at the processor may not travel through the closed-door pharmacy area.
- (2) Upon request, the licensee shall inform the department of how it implements the separation of materials, including the facility's separation procedures for raw material, extract, and final products.
KEY: medical cannabis, pharmacy, closed-door, violation categories, product recall, waste and disposal, licensing, storage and handling
Date of Last Change: December 22, 2025
Authorizing, and Implemented or Interpreted Law: 4-41a-1206(10)